biotech
Avatar therapy holds potential as adjunct therapy for schizophrenia
November 24, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, schizophrenia
Experts have developed a new form of therapy for patients living with schizophrenia, by allowing those individuals to speak to …
Drinking three cups of coffee found to hold health benefits
November 23, 2017Medical Communications biotech, coffee, drugs, pharma, pharmaceutical
In good news for coffee drinkers, drinking three to four cups of coffee was found to lower the risk of …
Online GP appointments found to be largely ineffective
November 23, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
There is a general push in the UK to find new digital means of reducing the workload on doctors and …
Teva looks set to axe thousands of positions and a big name
November 23, 2017Manufacturing and Production Teva, biotech, drugs, pharma, pharmaceutical
Teva’s troubled year needs little detailing, those following the company have seen it lurch from one piece of bad news …
Autumn Budget provides NHS with much-needed winter cash boost
November 22, 2017Medical Communications Autumn Budget, biotech, drugs, pharma, pharmaceutical
The Autumn Budget was announced and one of the few major announcements that had not been leaked prior to the …
Collaboration in Biopharma
November 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague, Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological …
‘Brain training’ found to reduce risk of dementia by 29%
November 22, 2017Research and Development biotech, dementia, drugs, pharma, pharmaceutical
In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …
EU approves opioid treatment, amid fears of US-like crisis
November 22, 2017Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical
The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …
Free Webinar: The End Game – Payer Engagement
November 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical
In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
NHS faced with 5,700% increase in drug price, finds CMA
November 21, 2017Manufacturing and Production, Medical Communications CMA, Concordia, biotech, drugs, pharma, pharmaceutical
The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of …
And the winner is…Amsterdam takes EMA HQ
November 21, 2017Manufacturing and Production, Medical Communications biotech, drugs, pharma, pharmaceutical
In a decision that was likened to a penalty shoot-out, Amsterdam was announced as the winner of the race to …
UK austerity measures to social care led to 120,000 deaths
November 17, 2017Medical Communications UK, austerity, biotech, drugs, pharma, pharmaceutical, social care
A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …
Roche’s haemophillia A treatment gets nod but with black box warning
November 17, 2017Medical Communications, Sales and Marketing Hemlibra, Roche, biotech, drugs, pharma, pharmaceutical
Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …
Boots under fire from Labour MPs over broken contraceptive promise
November 17, 2017Medical Communications, Sales and Marketing Boots, biotech, drugs, morning after pill, pharma, pharmaceutical
Boots, a UK high-street pharmacy, has come under pressure from Labour MPs after it failed to adhere to its own …
FDA approves electronic nerve stimulator for opioid withdrawal
November 16, 2017Sales and Marketing NNS-2 Bridge, biotech, drugs, opioid, pharma, pharmaceutical
A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to …
